Measurable Residual Disease Monitoring by Multiparameter Flow Cytometry and Relapse Prediction in Adult Acute Myeloid Leukemia. (2024). Annals of Leukemia Research, 5(1), 1-6. https://doi.org/10.5281/zenodo.22227540